Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedSite software revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision note updated to v3.4.3 and v3.4.2 was removed as part of the version history. No study data or user-facing functionality were changed.SummaryDifference0.1%

- Check40 days agoChange DetectedAdministrative updates to the Study Record Dates: new date entries (2026-02-18, 2026-04-30, 2026-02-17, 2026-02) were added and earlier dates (2026-01-16, 2026-02-27, 2026-01-15, 2026-01) were removed.SummaryDifference0.3%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding status notice (previously Revision: v3.4.1). These are minor site maintenance changes and do not affect the study details or user actions.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding affecting NIH operations and guidance to opm.gov, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedAdded UI elements and metadata fields: a Show glossary option; Last Update Submitted that Met QC Criteria and Last Update Posted; a site Revision indicator (Revision: v3.4.0) and No FEAR Act Data. Removed older items: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.